Evaluation of Human Efficacy for Skin Moisturization and Wrinkle Improvement
NCT ID: NCT05872113
Last Updated: 2023-05-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2021-10-01
2021-11-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Evaluate and Compare the Efficacy of Two Facial Creams on Moderately to Severely Photodamaged Skin
NCT06852742
Cream Short-term Efficacy Clinical Study
NCT07067086
Lotion and Toner Bundle 4-Week Lifting Efficacy Study
NCT07127653
Efficacy in Daily Use of a Novel Skin Care Product for the Treatment of Photoaged Skin
NCT03144193
Proof of Concept Anti-ageing Clinical Study in Healthy Subjects
NCT03180645
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
The subjects who were on a placebo were put on the cream two times per day for 4 weeks. The questionnaire for testing the effects progressed when before using the cream, after 2 weeks, and after 4 weeks.
Placebo cream
The cream was applied to the faces of subjects, the right facial area was put on the placebo cream.
Experiment
The subjects who were on experimental were put on the cream two times per day for 4 weeks. The questionnaire for testing the effects progressed when before using the cream, after 2 weeks, and after 4 weeks.
Hs-hWE cream
The cream was applied to the faces of subjects, the left facial area was put on the 0.5% Hs-WE cream.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo cream
The cream was applied to the faces of subjects, the right facial area was put on the placebo cream.
Hs-hWE cream
The cream was applied to the faces of subjects, the left facial area was put on the 0.5% Hs-WE cream.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The subject has eye wrinkles (crow's feet).
* A person who has voluntarily signed consent after fully explaining the test purpose and content.
* Those who can follow up during the test period.
* A healthy person without acute or chronic physical disease including skin disease.
Exclusion Criteria
* A person with a lesion at the test site or suffering from an infectious skin disease.
* People with allergies or hypersensitivity, or irritation to cosmetics, pharmaceuticals, or daily exposure to light.
* Those who have received systemic steroids or phototherapy within 1 month of participating in the trial, or who have received skin treatment (scaling/botox/filler/laser/tattoo) within 3 months of participating in the trial.
* Those who have used drugs with similar functions at the research site within 3 months before the start of the study, or have a mental illness, or mental retardation disorder.
* Other than the above, a person who will make it difficult to conduct a human test based on the judgment of the responsible researcher or the person in charge of the study.
30 Years
59 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
COSMAX
UNKNOWN
Global medical research center
UNKNOWN
Ji Hye Yoon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ji Hye Yoon
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sungkyunkwan university
Suwon, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GIRB-21929-NY
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.